YHP1604
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YHP1604, covering 2019-01-16 to 2019-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin [Phase 1]